HUMAX-CD20

EUIPO EUIPO 2006 Registration expired

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark HUMAX-CD20 was filed as Word mark on 02/28/2006 at the European Union Intellectual Property Office.
It was registered as a trademark on 03/16/2007. The current status of the mark is "Registration expired".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 004930244
Application date February 28, 2006
Publication date September 4, 2006
Entry date March 16, 2007
Expiration date February 28, 2016

Trademark owner

Carl Jacobsens Vej 30
2500 Valby
DK

Trademark representatives

Øster Allé 42, 6 2100 København Ø DK

goods and services

1 Chemicals used in industry, science and photography, including biochemicals, especially, monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases; none of these chemicals for use in scientific research and development in connection with respiratory infectious affections
5 Pharmaceutical, veterinary and sanitary preparations, including pharmaceutical preparations based on human monoclonal antibodies; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; none of the beforementioned preparations for the treatment of respiratory infectious affections
42 Medical scientific research, including biological research and especially research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies; chemical analysis, patent exploitation, licensing of intellectual property in the field of medicine; computer programming, including programming of computers for the collection and processing of medical data in medical scientific research development and therapy, including scientific research, development and therapy with monoclonal antibodies; except research and development in connection with respiratory infectious affections
44 Medical service, pharmacy advice, veterinary services; professional consultancy, namely consultancy with regard to treatment of patients with pharmaceutical products, especially with pharmaceutical products based on human monoclonal antibodies; except medical service and pharmacy advice in connection with respiratory infectious affections

Trademark history

Date Document number Area Entry
June 3, 2016 Change Representative, Published
November 21, 2012 Transfer / Change of address, Published
December 5, 2011 Change Representative, Published
November 30, 2010 Transfer / Change of address, Published
September 24, 2007 Correction, Published
September 17, 2007 Correction, Published

ID: 11004930244